<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CROTAMITON</span><br/>(kroe-tam'i-tonn)<br/><span class="topboxtradename">Eurax<br/></span><b>Classifications:</b> <span class="classification">skin and mucous membrane agent</span>; <span class="classification">scabicide</span>; <span class="classification">antipruritic</span><br/><b>Prototype: </b>Lindane<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>10% cream, lotion</p>
<h1><a name="action">Actions</a></h1>
<p>Scabicidal and antipruritic agent. Available in an emollient-lotion base or in a vanishing cream.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>By unknown mechanisms, drug eradicates <i>Sarcoptes scabiei</i> and effectively relieves itching.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of scabies and for symptomatic treatment of pruritus.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Application to acutely inflamed skin, raw or weeping surfaces, eyes, or mouth; history of previous sensitivity to crotamiton;
         pregnancy (category C).
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Scabies</span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">Topical</span> Apply a thin layer of cream from neck to toes; apply a second layer 24 h later. Bathe 48 h after last application to remove
               drug<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Shake container well before use of solution.</li>
<li>The skin must be thoroughly dry before applying medication.</li>
<li>If drug accidentally contacts eyes, thoroughly flush out medication with water.</li>
<li>Pruritus treatment: massage medication gently into affected areas until it is completely absorbed. Repeat as needed (usually
            effective for 610 h).
         </li>
<li>Store in tightly closed containers at 15°30° C (59°86° F). Do not freeze.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Skin:</span> Skin irritation (particularly with prolonged use), rash, erythema, sensation of warmth, allergic sensitization. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> No clinically significant interactions established. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for and report significant skin irritation or allergic sensitization.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Review package insert before treatment begins.</li>
<li>Discontinue medication and report to physician if irritation or sensitization develops.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>